Daniel Gilbert

• Business

Sam Altman is behind a start-up that aims to tap into the promise that psychedelic drugs have shown for mental health and drug disorders, and make them widely available.

• Business

Silicon Valley Bank's rapid growth raised internal concerns that were overshadowed in a culture of executives driven to deliver profits, former employees say.

• Business

Adults using prescription stimulants for attention-deficit/hyperactivity disorder sharply increased from 2020 to 2021, a government study found, the latest to highlight changes wrought by the pandemic.

• Business

It puts a spotlight on virtual prescribing and supply chain issues.

• Business

The drugmaker says the move will make the diabetes medication more accessible, especially for those who have trouble navigating the “complex health care system.”

• Business

Novo Nordisk said it would cut list prices of several of its insulin products by as much as 75 percent, the latest major producer to reduce prices following public pressure to curb the cost of diabetes treatment.

• Business

Pfizer said it will buy Seagen, a major push into cancer-fighting drugs as Pfizer remakes itself with financial windfall netted from its covid treatments.

• Business

Though their approaches vary, innovative companies like Paradromics and Synchron are trying to hack the brain’s instructions to the body and transmit them directly to an electronic device — enabling, for example, a person to move a cursor by thinking about it.

• Business

The price of the medication has become a political issue as diabetics have struggled to afford the lifesaving drug